Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
62
Number of overlapping holdings
100.0%
% of XLV's 62 holdings also in FHLC
18.0%
% of FHLC's 369 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus FHLC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XLV |
Weight in FHLC |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 12.0% | 10.2% | 10.2% | |
UNITEDHEALTH GROUP INC | 9.3% | 8.3% | 8.3% | |
JOHNSON & JOHNSON | 6.8% | 6.1% | 6.1% | |
ABBVIE INC | 5.9% | 5.2% | 5.2% | |
MERCK & CO. INC. | 5.0% | 5.0% | 5.0% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to FHLC
ELI LILLY & CO | 1.8% | |
INTUITIVE SURGICAL INC | 1.2% | |
UNITEDHEALTH GROUP INC | 1.0% | |
ABBOTT LABORATORIES | 0.9% | |
BOSTON SCIENTIFIC CORP | 0.8% | |
ABBVIE INC | 0.8% | |
JOHNSON & JOHNSON | 0.7% | |
STRYKER CORP | 0.7% | |
GILEAD SCIENCES INC | 0.7% | |
BRISTOL-MYERS SQUIBB CO | 0.6% |
XLV Underweight Relative to FHLC
ALNYLAM PHARMACEUTICALS INC | -0.5% | |
VEEVA SYSTEMS INC-CLASS A | -0.5% | |
MODERNA, INC. | -0.4% | |
REGENERON PHARMACEUTICALS | -0.3% | |
ILLUMINA INC | -0.3% | |
AVANTOR, INC. | -0.3% | |
BIOMARIN PHARMACEUTICAL INC | -0.2% | |
UNITED THERAPEUTICS CORP | -0.2% | |
NEUROCRINE BIOSCIENCES INC | -0.2% | |
ELEVANCE HEALTH INC | -0.2% |